Revvity | PKI - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
Agilent 20.53 4.51 2026-03
Align Technology 21.8 0.98 2026-06
Bio Techne 38.75 81.27 2026-03
Bio-Rad Laboratories 48.85 38.84 2026-06
Bruker 46.54 9.74 2026-06
Celltrion 58.97 8.86 2026-03
Charles River Laboratories 58.27 29 2026-06
Cspc Pharmaceutical 23.62 0.78 2026-03
Danaher 32.68 3.4 2026-06
Dentsply International 20.31 9.68 2026-03
Deva Holding AS 6.55 2.01 2023-09
Dianthus Therapeutics 3.8 1.53 2024-09
Divis Laboratories Ltd 58.35 1.4 2026-06
Edwards Lifesciences 30.77 3.9 2026-06
Illumina 48.98 16.53 2026-06
Intuitive Surgical 44.59 11.23 2026-06
IQVIA Holdings 21.45 2.08 2026-06
Kangmei Pharma 1.11K 2.04K 2026-03
Knight Therapeutics 257.34 166.24 2025-12
Laboratorios Farma 18.78 6.64 2023-12
Laboratory Of America 20.47 5.04 2026-06
Malin Corporation 11.81 0.72 2023-06
Mettler Toledo International 27.29 0.04 2026-06
Neuren Pharmaceuticals 72.14 59.86 2025-12
OraSure Technologies 24.42 12.6 2024-09
Organigram Holdings 12.01 222.99 2026-03
Ovoca Bio 1.83 3.29 2024-06
Pharma Mar 16.35 2.78 2026-06
Qiagen NV 16.72 2.76 2026-06
Quest Diagnostics 21.23 1.17 2026-06
Quidel 2.03 70.39 2025-12
Repligen 105.09 4.39 2026-06
Revvity 36.47 5.68 2026-06
Sartorius 52.99 9.56 2026-06
Sino Biopharmaceutical 17.03 0.89 2025-06
Thermo Fisher Scientific 26.4 1.31 2026-06
Tilray 11.56 80.19 2025-09
Waters 66.69 36.94 2026-06
Zealand Pharma A/S 3.27 1.86 2026-03
Zz Pientze Pharmaceu 47.68 1.35 2026-03